
Dr. Yi Xin
Founder, Chairman & CEO
Dr. Yi holds a Ph.D. from the Beijing Institute of Genomics, Chinese Academy of Sciences, and is a Professorate Senior Engineer with over a decade of research experience in genomics and translational medicine. Deeply rooted in precision medicine, he focuses on clinical research and translational applications across oncology, infectious diseases, and organ health, and has led the development and commercialization of multiple flagship products. In recent years, he has directed 13 major research projects, with groundbreaking findings published in leading journals including Science, Nature, Nature Genetics, Nature Medicine, and Cancer Discovery. He has also played a pivotal role in shaping national standards and expert consensus for multi-omics testing, advancing the adoption of AI-powered multi-omics technologies across China.















